HQH (abrdn Healthcare Investors) Piotroski F-Score: 2 (As of Jun. 27, 2026) — 50% Below Median


HQH abrdn Healthcare Investors HQH
40 GF Score
Price $21.63
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors Piotroski F-Score?

abrdn Healthcare Investors HQH +1.93% 40 Piotroski F-Score is 2 as of Jun. 27, 2026, which is 50% below its 10-year median of 4.00. GuruFocus rates HQH with a GF Score™ of 40/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,597 Asset Management companies, abrdn Healthcare Investors ranks worse than 90.86% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

abrdn Healthcare Investors has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for abrdn Healthcare Investors's Piotroski F-Score or its related term are showing as below:

HQH' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 2

During the past 9 years, the highest Piotroski F-Score of abrdn Healthcare Investors was 5. The lowest was 2. And the median was 4.

abrdn Healthcare Investors  (NYSE:HQH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


abrdn Healthcare Investors Piotroski F-Score Related Terms


abrdn Healthcare Investors Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for abrdn Healthcare Investors's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Healthcare Investors Piotroski F-Score Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 2.00 4.00 5.00 5.00 2.00

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.00 0.00 2.00 0.00

HQH vs FPF, AOD, CRF: Piotroski F-Score Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors Piotroski F-Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Piotroski F-Score falls into.


HQH
40GF Score
abrdn Healthcare Investors HQH
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep25) TTM:Last Year (Sep24) TTM:
Net Income was $98.6 Mil.
Cash Flow from Operations was $0.0 Mil.
Revenue was $99.8 Mil.
Average Total Assets from the begining of this year (Sep24)
to the end of this year (Sep25) was (1060.991 + 1097.258) / 2 = $1079.1245 Mil.
Total Assets at the begining of this year (Sep24) was $1,061.0 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.
Total Assets was $1,097.3 Mil.
Total Liabilities was $3.4 Mil.
Net Income was $184.9 Mil.

Revenue was $186.5 Mil.
Average Total Assets from the begining of last year (Sep23)
to the end of last year (Sep24) was (932.492 + 1060.991) / 2 = $996.7415 Mil.
Total Assets at the begining of last year (Sep23) was $932.5 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.
Total Assets was $1,061.0 Mil.
Total Liabilities was $1.4 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

abrdn Healthcare Investors's current Net Income (TTM) was 98.6. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

abrdn Healthcare Investors's current Cash Flow from Operations (TTM) was 0.0. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep24)
=98.613/1060.991
=0.09294424

ROA (Last Year)=Net Income/Total Assets (Sep23)
=184.947/932.492
=0.19833629

abrdn Healthcare Investors's return on assets of this year was 0.09294424. abrdn Healthcare Investors's return on assets of last year was 0.19833629. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

abrdn Healthcare Investors's current Net Income (TTM) was 98.6. abrdn Healthcare Investors's current Cash Flow from Operations (TTM) was 0.0. ==> 0.0 <= 98.6 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep24 to Sep25
=0/1079.1245
=0

Gearing (Last Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=0/996.7415
=0

abrdn Healthcare Investors's gearing of this year was 0. abrdn Healthcare Investors's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

* Note that for banks and insurance companies, there's no Total Current Assets and Total Current Liabilities reported. Thus, we use Total Assets and Total Liabilities to calculate current ratio for banks and insurance companies.

Current Ratio (This Year: Sep25)=Total Assets/Total Liabilities
=1097.258/3.429
=319.99358414

Current Ratio (Last Year: Sep24)=Total Assets/Total Liabilities
=1060.991/1.395
=760.56702509

abrdn Healthcare Investors's current ratio of this year was 319.99358414. abrdn Healthcare Investors's current ratio of last year was 760.56702509. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

abrdn Healthcare Investors's number of shares in issue this year was 61.25. abrdn Healthcare Investors's number of shares in issue last year was 52.393. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

* Note that for banks and insurance companies, there's no Gross Profit reported. Thus, we use net income instead of gross profit and calculate Net Margin for this score.

Net Margin (This Year: TTM)=Net Income/Revenue
=98.613/99.813
=0.98797752

Net Margin (Last Year: TTM)=Net Income/Revenue
=184.947/186.457
=0.99190162

abrdn Healthcare Investors's net margin of this year was 0.98797752. abrdn Healthcare Investors's net margin of last year was 0.99190162. ==> Last year's net margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep24)
=99.813/1060.991
=0.09407526

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep23)
=186.457/932.492
=0.1999556

abrdn Healthcare Investors's asset turnover of this year was 0.09407526. abrdn Healthcare Investors's asset turnover of last year was 0.1999556. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

abrdn Healthcare Investors has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
abrdn Healthcare Investors (HQH) has a Piotroski F-Score of 2 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on abrdn Healthcare Investors and its competitors. This is 50% below median its historical median of 4.00. Over the past decade, abrdn Healthcare Investors' Piotroski F-Score has ranged from 2.00 to 5.00. According to the industry distribution chart, abrdn Healthcare Investors ranks #1451 out of 1597 companies in the Asset Management industry, placing it in the top 90.9%.
Is abrdn Healthcare Investors' Piotroski F-Score too high?
abrdn Healthcare Investors' current Piotroski F-Score of 2 is 50% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.00. The Asset Management industry median Piotroski F-Score is 5.00. abrdn Healthcare Investors' value of 2 is 60% below this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #1451 out of 1597 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' Piotroski F-Score compare to FPF and AOD?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #1451 out of 1597 companies for Piotroski F-Score. This places abrdn Healthcare Investors in the lower half of its industry. The industry median Piotroski F-Score is 5.00. abrdn Healthcare Investors' value of 2 is 60% below this benchmark. Historically, abrdn Healthcare Investors' own Piotroski F-Score has ranged from 2.00 to 5.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, abrdn Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Asset Management company?
The median Piotroski F-Score among Asset Management companies is 5.00, based on 1,597 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current Piotroski F-Score is 2, which is 50% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.63 — trading 57% below its estimated fair value. The current Piotroski F-Score is 2, which is 50% below median its 10-year median of 4.00 and 60% below the Asset Management industry median of 5.00. abrdn Healthcare Investors' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current Piotroski F-Score is 2 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $21.63 is trading 57% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • Piotroski F-Score: 2 (50% below median its 10-year median of 4.00)
  • GF Value™: $50.26 vs. price of $21.63 (57% below fair value)
  • GF Score™: 40/100 with 6 warning signs
  • Industry Position: 60% below the Asset Management median (#1451 of 1597)

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
40GF Score

Get the complete analysis for HQH

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.63
Price
$50.26
GF Value